Stoke Therapeutics (STOK) Asset Utilization Ratio (2022 - 2026)

Stoke Therapeutics' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.07 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 86.77% year-over-year to 0.07 in Q1 2026; TTM through Mar 2026 was 0.07, a 86.77% decrease from a year earlier, with the FY2025 full-year figure at 0.53, up 265.51% from the prior year.
• Asset Utilization Ratio fell to 0.07 in Q1 2026 per STOK's latest filing, from 0.47 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.56 in Q1 2025 and bottomed at 0.05 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.06 (2024), against an average of 0.2.
• Across the five-year window, Asset Utilization Ratio jumped 891.2% in 2025 and tumbled 86.77% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.05 in 2022, then grew by 26.28% to 0.06 in 2023, then soared by 120.48% to 0.13 in 2024, then soared by 265.97% to 0.47 in 2025, then plunged by 84.28% to 0.07 in 2026.
• Per Business Quant, the three latest STOK Asset Utilization Ratio figures stand at 0.07 (Q1 2026), 0.47 (Q4 2025), and 0.55 (Q3 2025).